The latest thoracic oncology news
Engineering extracellular vesicles
In the quest for more targeted lung cancer treatments, a researcher at the University of…
The latest thoracic oncology news
In the quest for more targeted lung cancer treatments, a researcher at the University of…
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100…
The first-in-class YAP-TEAD inhibitor VT3989 continued to be well-tolerated and demonstrated notable initial antitumor activity, particularly…
The health of the thymus – a key part of the body’s immune system -…
Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful…
Researchers have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while…
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy…
About five percent of lung adenocarcinomas, one of the most common forms of lung cancer,…
Small cell lung cancer cells that metastasise to the brain cosy up to neurons and…
A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes…